跳至主要内容
临床试验/NCT04895631
NCT04895631招募中3 期

18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Thomas Hope1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2021年6月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
招募中
发起方
Thomas Hope
入组人数
140
试验地点
1
主要终点
Proportion of participants with true-positives (sensitivity) of 18F-Fluorocholine PET using sestamibi imaging

研究概览

简要总结

This is a prospective single arm single center Phase III study evaluating the ability of 18F-fluorocholine to detect the location of parathyroid adenomas.

详细描述

PRIMARY OBJECTIVE:

I. To investigate the performance (accuracy) of 18F-fluorocholine PET in the detection of hyperfunctioning parathyroid glands in surgical patients with biochemically proven primary hyperparathyroidism.

OUTLINE:

Participants will receive a single dose of 18F-Fluorocholine at the time the participant undergoes a single imaging study using 18F-fluorocholine. Study related procedures will end after the study visit. Participants who undergo subsequent parathyroidectomy, will have the results reviewed and compared to the results from the imaging study

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
13 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >= 13 years.
  • Biochemically proven hyperparathyroidism and an indication for surgery.
  • Ability to understand a written informed consent document, and the willingness to sign it.

排除标准

  • Current Pregnancy.
  • Patients unlikely to comply with study procedures, restrictions and requirements and judged by the Investigator to be unsuitable for study participation.

研究组 & 干预措施

Fluorocholine PET Imaging

Experimental

Patients will undergo a single fluorocholine PET imaging study prior to surgery.

干预措施: 18F-Fluorocholine (Drug)

Fluorocholine PET Imaging

Experimental

Patients will undergo a single fluorocholine PET imaging study prior to surgery.

干预措施: Positron emission tomography (PET) (Procedure)

结局指标

主要结局

Proportion of participants with true-positives (sensitivity) of 18F-Fluorocholine PET using sestamibi imaging

时间窗: Up to 1 year

Sensitivity of 18F-fluorocholine PET for the detection of abnormal parathyroid adenomas confirmed by pathology as compared to sestamibi imaging. Location of parathyroid adenoma at imaging as read by three blinded readers, will be correlated to the location at surgery. True positive will be defined as an adenoma on imaging in the same location as seen at surgery. Sensitivity will be reported by individual reader.

Proportion of participants with true-positives (sensitivity) of 18F-Fluorocholine PET using predefined threshold

时间窗: Up to 1 year

Sensitivity of 18F-fluorocholine PET for the detection of abnormal parathyroid adenomas confirmed by pathology compared to a predefined threshold. Location of parathyroid adenoma at imaging as read by three blinded readers, will be correlated to the location at surgery. True positive will be defined as an adenoma on imaging in the same location as seen at surgery. Sensitivity will be reported by individual reader.

次要结局

  • Detection rate of 18F-fluorocholine PET(Up to 1 year)

研究者

发起方
Thomas Hope
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Thomas Hope

Associate Professor

University of California, San Francisco

研究点 (1)

Loading locations...

相似试验

Enrolling By Invitation
3 期
Fluorocholine PET/CT Basket TrialFluorocholine PET/CT
NCT04150458Sir Mortimer B. Davis - Jewish General Hospital2,000
撤回
早期 1 期
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue SarcomaStage II Adult Soft Tissue SarcomaStage IIA Adult Soft Tissue SarcomaStage IIB Adult Soft Tissue SarcomaStage IIC Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaStage IV Adult Soft Tissue Sarcoma
NCT03613259OHSU Knight Cancer Institute
已完成
早期 1 期
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical CystectomyUrothelial CarcinomaBladder Cancer
NCT04018053Brigham and Women's Hospital16
已完成
早期 1 期
18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing SarcomaAdult Supratentorial Primitive Neuroectodermal Tumor (PNET)Ewing Sarcoma of BoneExtraosseous Ewing SarcomaLocalized Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorMetastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorUntreated Childhood Supratentorial Primitive Neuroectodermal Tumor
NCT01825902Mayo Clinic1
已完成
2 期
Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone MetastasesHormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate CarcinomaStage IV Prostate Cancer
NCT00936975National Cancer Institute (NCI)18